Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa India), led by Lightrock India
Bugworks Research, a clinical stage multi-indication therapeutics company, today announced the financing of US$18M Series B1.
Source: zimbabwestar.com